Wearable tDCS and Acute Golf Shot Performance

November 1, 2026 updated by: Hongbin Xiang, Shanghai University of Sport

Acute Effects of Wearable Transcranial Direct Current Stimulation on Golf Shot Performance: a Randomized, Sham-controlled Trial

Transcranial direct current stimulation (tDCS) has been investigated as an ergogenic aid for two decades, but most sport evidence comes from laboratory stimulators operated by experimenters. This trial evaluates whether a single 20-minute session of wearable, app-controlled bilateral motor-cortex tDCS (Halo Sport 2, 2 mA) improves full-swing golf shot performance compared with sham stimulation. The study is a double-blind, sham-controlled, parallel-group randomized trial with a pre-test/post-test design in golfers stratified into professional, amateur-high, and amateur-middle skill groups. Each participant attends a single session comprising a 40-shot pre-test, 20 minutes of real or sham stimulation, and a 40-shot post-test, with shots measured by a TrackMan 4 launch monitor across eight standardized club categories. The primary outcomes are change scores (post minus pre) in carry distance, ball speed, smash factor, within-player carry-distance variability, and absolute lateral deviation. Effects will be examined overall and as a function of skill level (categorical group and continuous golf handicap).

Study Overview

Detailed Description

Participants are stratified by skill level (professional, amateur-high, amateur-middle) and sex, and randomly assigned 1:1 to real or sham stimulation using a computer-generated sequence; allocation is concealed from the testing team. Real stimulation: Halo Sport 2 headset, bilateral primary motor cortex (approximately C3/C4), 2 mA for 20 minutes (30-s ramp up and down), controlled by smartphone app. Sham: identical device and app procedure with a 30-s current ramp-up followed immediately by ramp-down and no sustained current; the app does not display the stimulation mode. Each participant attends one session: 10-min standardized warm-up, 40-shot pre-test, 20-min stimulation, 40-shot post-test. Shot outcomes (carry distance, ball speed, smash factor, spin rate, launch angle, launch direction, club speed, attack angle, face-to-path) are recorded with a TrackMan 4 launch monitor; within-player variability (SD of five shots) is computed per club category (Driver, 3-wood, hybrid, 5-iron, 7-iron, 9-iron, 70-yd wedge task, 100-yd wedge task). Analyses use linear mixed models with likelihood-ratio tests; skill-dependent moderation is tested categorically (group) and continuously (handicap linear and quadratic interactions) with false-discovery-rate correction. Anonymized participant-level data and analysis scripts will be made available in a public repository (Zenodo, https://doi.org/10.5281/zenodo.22684611).

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, China, 200438
        • Shanghai University of Sport, School of Physical Education

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥ 16 years;
  • at least 2 years of systematic golf training;
  • own set of clubs covering the standardized test clubs;
  • right-handedness;
  • normal or corrected-to-normal vision;
  • no musculoskeletal injury in the previous 6 months that would affect the golf swing.

Exclusion Criteria:

  • History of neurological or psychiatric disease; epilepsy;
  • metal implants in the head; pregnancy;
  • skin lesions under the electrode sites;
  • current use of central-nervous-system-active medication;
  • migraine within the previous year.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Real tDCS

Single 20-minute session of 2 mA transcranial direct current stimulation delivered by a wearable headset (Halo Sport 2, fixed configuration): anode 24 cm² at Cz, return electrodes 16 cm² at C5 and C6, 30-second ramp-up and ramp-down. Anode current density approximately 0.083 mA/cm².

Participants stratified by skill group (professional / amateur-high / amateur-middle) and sex, then randomly assigned 1:1 to real or sham stimulation

Sham Comparator: Sham tDCS

Identical headset and electrode placement with a 30-second ramp-up followed immediately by ramp-down, delivering no effective current.

Participants stratified by skill group (professional / amateur-high / amateur-middle) and sex, then randomly assigned 1:1 to real or sham stimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Carry distance change
Time Frame: Baseline and immediately after intervention (same-day single session)

Post minus pre carry distance (yards), per club category

Baseline and immediately after intervention (same-day single session)
Ball speed change
Time Frame: Baseline and immediately after intervention (same-day single session)

Post minus pre ball speed (mph), per club category

Baseline and immediately after intervention (same-day single session)
Smash factor change
Time Frame: Baseline and immediately after intervention (same-day single session)

Post minus pre smash factor (ball speed / club speed), per club category

Baseline and immediately after intervention (same-day single session)
Carry distance variability change
Time Frame: Baseline and immediately after intervention (same-day single session)

Post minus pre within-player SD of the five shots per club category (yards)

Baseline and immediately after intervention (same-day single session)
Absolute lateral deviation change
Time Frame: Baseline and immediately after intervention (same-day single session)

Post minus pre absolute carry-side deviation (yards), per club category |

Baseline and immediately after intervention (same-day single session)

Secondary Outcome Measures

Outcome Measure
Time Frame
Total distance change
Time Frame: Baseline and immediately after intervention (same-day single session)
Baseline and immediately after intervention (same-day single session)
Spin rate change
Time Frame: Baseline and immediately after intervention (same-day single session)
Baseline and immediately after intervention (same-day single session)
Launch angle change
Time Frame: Baseline and immediately after intervention (same-day single session)
Baseline and immediately after intervention (same-day single session)
Absolute face-to-path change
Time Frame: Baseline and immediately after intervention (same-day single session)
Baseline and immediately after intervention (same-day single session)
Absolute launch direction change
Time Frame: Baseline and immediately after intervention (same-day single session)
Baseline and immediately after intervention (same-day single session)
Club head speed change
Time Frame: Baseline and immediately after intervention (same-day single session)
Baseline and immediately after intervention (same-day single session)
Attack angle change
Time Frame: Baseline and immediately after intervention (same-day single session)
Baseline and immediately after intervention (same-day single session)
Ball speed variability change(within-player SD of five shots)
Time Frame: Baseline and immediately after intervention (same-day single session)
Baseline and immediately after intervention (same-day single session)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2025

Primary Completion (Actual)

December 31, 2025

Study Completion (Actual)

December 31, 2025

Study Registration Dates

First Submitted

September 14, 2026

First Submitted That Met QC Criteria

September 18, 2026

First Posted (Actual)

September 24, 2026

Study Record Updates

Last Update Posted (Actual)

November 3, 2026

Last Update Submitted That Met QC Criteria

November 1, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 102772025RT109

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymized participant-level dataset and analysis scripts

IPD Sharing Time Frame

Available now, indefinitely

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe